Organism: Homo sapiens
Gene: 39120_at
Selected probe(set): 208581_x_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 39120_at (208581_x_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-4.735942
Number of Samples:2 / 10

Experimental	HCC study 9 (HBV; HCV)
	Liver tissue biopsy sample from patients with Hepatitis B and C infection related hepatocellular carcinoma (HCC) after resection.
Control	normal liver tissue
	Normal, non-tumor liver tissue.

Relative Expression (log2-ratio):-4.602545
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic crypt)
	Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	adjacent colonic crypt epithelial cell sample
	Adjacent colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from patients with colorectal cancer.

Relative Expression (log2-ratio):4.5418034
Number of Samples:2 / 2

Experimental	ovarian tumor study 30 (PDX; mixed tumor, malignant, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary mixed tumor, malignant, NOS of the ovary (subcutaneously implanted).
Control	ovarian tumor study 30 (PDX; adenocarcinoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary adenocarcinoma, NOS of the ovary (subcutaneously implanted).

Relative Expression (log2-ratio):-4.5318165
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	normal colon mucosa sample
	Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):-4.4950314
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic mucosa)
	Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	adjacent colon mucosa sample
	Adjacent colon mucosa sample obtained by laser capture microdissection (LCM) from patients with colorectal cancer.

Relative Expression (log2-ratio):-4.2871227
Number of Samples:4 / 4

Experimental	stem cell differentiation study 59 (8d)
	WA09 embryonic stem cell samples differentiated for 8 days. Further details are described in the paper.
Control	normal embryonic stem cell sample (WA09)
	Undifferentiated WA09 embryonic stem cell samples.

Relative Expression (log2-ratio):-4.170802
Number of Samples:3 / 10

Experimental	HCC study 9 (alcohol; HBV)
	Liver tissue biopsy sample from patients with alcohol abuse and Hepatitis B infection related hepatocellular carcinoma (HCC) after resection.
Control	normal liver tissue
	Normal, non-tumor liver tissue.

Relative Expression (log2-ratio):-4.0907764
Number of Samples:5 / 5

Experimental	colorectal cancer study 33 (carcinoma; colonic crypt)
	Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control	normal colonic crypt epithelial cell sample
	Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

Relative Expression (log2-ratio):3.982379
Number of Samples:3 / 3

Experimental	TGF-ß study 5 (late)
	Human A549 cells were treated with 5ng/ml porcine TGF-ß after serum-starving for 24h. Samples were taken 72 hours after TGF-ß treatment.
Control	untreated A549 cell sample
	A549 cells were grown for 24 hours. Samples were taken immediately before TGF-ß treatment.

Relative Expression (log2-ratio):-3.8180113
Number of Samples:3 / 3

Experimental	dendritic cell study 7 (IL-4 mddc)
	Mature IL-4 dendritic cells differentiated from CD14+ monocytes obtained from healthy donors. Monocytes were seeded in RPMI and supplemented with 2.5 % heat-inactivated human AB serum. Monocytes were cultured with 800 IU/mL granulocyte macrophage colony-stimulating factor and 20 ng/mL IL-4 in order to generate immature IL-4 DCs. Conventional maturation cocktail, comprising 10 ng/mL tumor necrosis factor-α, 10 ng/mL interleukin-1β, 15 ng/ml interleukin-6 and 1 µg/mL prostaglandin E2 was added for 48 hours. CD14+ monocytes were isolated from peripheral blood mononuclear cells (PBMC) by Ficoll density gradient centrifugation and purified by positive magnetic cell selection.
Control	dendritic cell study 7 (IL-15 mddc)
	Mature IL-15 dendritic cells differentiated from CD14+ monocytes obtained from healthy donors. Monocytes were seeded in RPMI and supplemented with 2.5 % heat-inactivated human AB serum. Differentiation was induced with 800 IU/mL granulocyte macrophage colony-stimulating factor and 200 ng/mL IL-15 to obtain immature IL-15 DCs. A TLR-activating maturation cocktail, comprising 3 µg/mL R848, 2.5 ng/mL tumor necrosis factor-α, 250 ng/mL interferon-γ and 1 µg/mL prostaglandin E2 was added after 24-48 hours of differentiation for 18-20 hours. CD14+ monocytes were isolated from peripheral blood mononuclear cells (PBMC) by Ficoll density gradient centrifugation and purified by positive magnetic cell selection.